New drug combo shows promise for rare gut tumors
NCT ID NCT03950609
First seen Jan 10, 2026 · Last updated May 11, 2026 · Updated 21 times
Summary
This study tests two drugs, lenvatinib and everolimus, given together to people with advanced carcinoid tumors that cannot be removed by surgery. The goal is to see if the combination can shrink tumors or slow their growth. 36 adults with measurable disease are taking part. This is not a cure; patients will need ongoing treatment to manage their cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.